Gujarat Exclusive >

covid 19 vaccine

85-year-old man in Bihar claims he has got 11 shots of Covid vaccine

Madhepura: At a time when even healthcare and frontline workers have not started getting the precaution (booster) dose of Covid vaccine, a senior citizen man in Bihar, reportedly aged 85, claims he has already received it 11 times. Meet Brahmdeo Mandal, a retired postman living in Madhepura district of Bihar, who has left everyone behind...

Govt intensifies fight; approves 2 Covid-19 vaccines, anti-viral drug in a day

New Delhi: Amid rising cases of Covid-19, including the ones caused by Omicron variant, the Union Health Ministry has given approval to two vaccines and an anti-viral drug, all in a day. The vaccines that have got emergency use approval are Corbevax, which is India’s first indigenously developed RBD protein sub-unit vaccine against Covid-19, Union...

Single-dose of COVID-19 vaccine 96.6% effective in preventing death: Centre

The Union government on Thursday said that a single dose of the COVID-19 vaccine is effective 96.6 per cent in preventing death whereas a double dose of the vaccine pushes efficacy to 97.5 per cent. The efficacy figures are based on data between April and August and the government has said that most deaths in...

Teachers’ Day: Mansukh Mandaviya announces 2 cr additional COVID vaccine doses for teachers

The Centre is going to provide around 2 crore additional COVID-19 doses to the states for vaccinating all school teachers on priority ahead of Teachers’ Day, which is celebrated on September 5. Notably, schools are shut since March last year to contain the spread of COVID-19 and to safeguard children from the deadly virus. While...

Brazil suspends Covaxin deal worth $324 million over allegations of irregularities

As per the deal, Bharat Biotech was to supply 20 million doses of the Covid-19 vaccine Brasilia: In wake of allegations of irregularities, the Brazilian government has suspended a $324 million contract with Bharat Biotech for purchase of its Covid-19 vaccine ‘Covaxin’. The deal for purchase of 20 million doses of the vaccine had been...

India pips US in COVID-19 vaccination—Here are the details

With India fast-tracking its immunization drive against COVID-19, it has now pipped the US in terms of the total number of doses administered so far. The development comes even though the US started its vaccination drive ahead of India. As per the latest data, India has so far administered 32.36 core doses against 32.33 crore...

India relaxes norms for foreign vaccine makers to fast-track import of jabs

The Indian drug regulator—the Drugs Controller General of India—has waived off the requirement of a bridging trial in India for foreign vaccines that have received clearance from WHO and health regulators of specific countries. The move is being seen as a major step by the government to pave the way for the entry of foreign...

Centre issues fresh guidelines to contain spread of COVID-19 in India

With COVID-19 cases rising rapidly since the fast few weeks, the Ministry of Home Affairs has issued fresh guidelines for the effective control of the viral infection. The guidelines will come into force on April 1 and will remain valid till April 30. Under the new guidelines, the states and Union Territories have been asked...

All above 45 can take COVID-19 vaccine from April 1: Centre

The Union government on Tuesday announced that all people above 45 years can avail of vaccination against COVID-19 from April 1 onwards. The announcement comes at a time when COVID-19 cases are rising rapidly and India’s immunization drive is running at a slower-than-expected rate. Union minister Prakash Javadekar, while announcing the cabinet decision, appealed to...

India’s Stelis Biopharma to produce 200 million doses of Russia’s Sputnik V

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Stelis Biopharma have partnered to produce and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 million people. The agreement between RDIF and Stelis Biopharma was reached under the aegis of Enso Healthcare LLP...

EU nations to resume rollout of AstraZeneca jab after regulator says its “safe”

Several members of the European Union (EU) who had stopped the rollout of AstraZeneca’s COVID-19 jab earlier this week over safety concerns have said that they will resume the rollout. The EU members include Germany, Italy, the Netherlands, France, Spain, Latvia, Lithuania, Slovenia, Bulgaria and Portugal. The development comes after the EU regulator, European Medicines...

EU nations halt use of AstraZeneca’s COVID-19 jab over safety concern

Even as the World Health Organisation (WHO) and European Union’s (EU) vaccine regulator insisted that the COVID-19 jab developed by AstraZeneca and the University of Oxford is safe to use, several EU countries have halted its rollout over fears of blood clots. Germany, Italy, France, Spain, Portugal, Slovenia and Latvia have halted the rollout of...